ERNA
ErnexaยทNASDAQ
--
--(--)
--
--(--)
ERNA Profile
Ernexa Therapeutics Inc.
A biopharmaceutical company that developing transformational new medicines
10355 Cambridge Street, Suite 18A, Cambridge, MA 02141
--
Ernexa Therapeutics Inc was incorporated in Delaware in 1984. Ernexa is an advanced clinical-stage biopharmaceutical company focused on IL-2 cytokine-based therapies for the treatment of cancer patients. Ernexa is committed to the development of IRX-2, a novel cytokine-based therapy for the treatment of cancer patients. IRX-2 active ingredients, namely IL-2 and other key cytokines, are assumed to signal, enhance and restore immune function suppressed by tumors, enabling the immune system to attack cancer cells.
